Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Ann Rheum Dis. 2017 Dec 15;77(5):678–683. doi: 10.1136/annrheumdis-2017-212407

Table 2. Aggregate Relative Importances.

Attribute Mean (SD) Relative Importances
Cost 24.66 (13.46)
Bothersome side effects 20.73 (10.35)
Very rare side effects 13.66 (9.03)
Onset of action 11.50 (7.16)
Serious infection 11.01 (6.68)
Route of administration 10.66 (8.60)
Time on the market 7.78 (4.79)